AR024114A1 - Antigeno (c42) asociado a tumores - Google Patents

Antigeno (c42) asociado a tumores

Info

Publication number
AR024114A1
AR024114A1 ARP000102577A ARP000102577A AR024114A1 AR 024114 A1 AR024114 A1 AR 024114A1 AR P000102577 A ARP000102577 A AR P000102577A AR P000102577 A ARP000102577 A AR P000102577A AR 024114 A1 AR024114 A1 AR 024114A1
Authority
AR
Argentina
Prior art keywords
tumors
antigen
encode
well
dna molecules
Prior art date
Application number
ARP000102577A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR024114A1 publication Critical patent/AR024114A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Antígeno asociado a tumores, péptidos inmunogenos derivados de éste, y moléculas de ADN que lo codifican, así como su utilizacion en la inmunoterapia deenfermedades de cáncer.
ARP000102577A 1999-05-27 2000-05-26 Antigeno (c42) asociado a tumores AR024114A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19924199A DE19924199A1 (de) 1999-05-27 1999-05-27 Tumorassoziiertes Antigen

Publications (1)

Publication Number Publication Date
AR024114A1 true AR024114A1 (es) 2002-09-04

Family

ID=7909293

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102577A AR024114A1 (es) 1999-05-27 2000-05-26 Antigeno (c42) asociado a tumores

Country Status (10)

Country Link
EP (1) EP1183349A1 (es)
JP (1) JP2003501025A (es)
AR (1) AR024114A1 (es)
AU (1) AU4924000A (es)
CA (1) CA2376133A1 (es)
CO (1) CO5280140A1 (es)
DE (1) DE19924199A1 (es)
MX (1) MXPA01012012A (es)
UY (1) UY26170A1 (es)
WO (1) WO2000073438A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338937B2 (en) * 1997-11-17 2008-03-04 Cornell Research Foundation, Inc. Calcium-activated chloride channel proteins and their use in anti-metastatic therapy
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US7141365B2 (en) 2001-05-18 2006-11-28 Syntex (U.S.A.) Llc Methods for diagnosing a mucin production associated disease condition
EP2314712B1 (en) 2001-11-07 2014-01-08 Mannkind Corporation Expression vectors encoding epitopes of antigens and methods for their design
US20050221350A1 (en) 2002-05-29 2005-10-06 Toni Weinschenk Method for identifying immunoreactive peptides
DE102005041616B4 (de) * 2005-09-01 2011-03-17 Johannes-Gutenberg-Universität Mainz Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und für diese kodierende Polynukleotide und deren Verwendungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002533056A (ja) * 1998-03-18 2002-10-08 コリクサ コーポレイション 肺癌の治療および診断のための化合物および方法
WO2000012711A2 (en) * 1998-09-02 2000-03-09 Incyte Pharmaceuticals, Inc. Human membrane channel proteins

Also Published As

Publication number Publication date
UY26170A1 (es) 2000-12-29
AU4924000A (en) 2000-12-18
EP1183349A1 (de) 2002-03-06
DE19924199A1 (de) 2000-11-30
CO5280140A1 (es) 2003-05-30
WO2000073438A1 (de) 2000-12-07
CA2376133A1 (en) 2000-12-07
JP2003501025A (ja) 2003-01-14
MXPA01012012A (es) 2002-06-21

Similar Documents

Publication Publication Date Title
CY1119291T1 (el) Πολυσθενη αντισωματα και χρησεις για αυτα
MXPA05008128A (es) Peptidos derivados de survivina y uso de los mismos.
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY1109468T1 (el) Χρησεις ανταγωνιστων της il-23. σχετικα αντιδραστηρια
AU2003242305A1 (en) Hla-a24-restricted cancer antigen peptide
TW581808B (en) Compounds for immunotherapy of prostate cancer and methods for their use
AR038568A1 (es) Anticuerpos anti-a beta y su uso
CY1108960T1 (el) Αντισωματα αποκλεισμου cripto και οι χρησεις τους
ZA200200097B (en) Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof.
WO2004050707A3 (de) Tumorspezifische erkennungsmoleküle
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
BR0306715A (pt) Métodos para diagnóstico e tratamento de tumores
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
MXPA05008794A (es) Antigeno de glicoproteina sima135 expresado en celulas tumorales humanas metastasicas.
AU8727201A (en) Genes involved in intestinal inflammatory diseases and use thereof
DE60315827D1 (de) Verbesserte polysaccharid- und glykokonjugat-vakzine
UY26266A1 (es) Antigeno asociado con tumores (r11) ley 17164
DK1082423T3 (da) Cyclin E2-gener og -proteiner
AR024114A1 (es) Antigeno (c42) asociado a tumores
MY141459A (en) Recombinant anti-idiotypic antibodies
AR023794A1 (es) Antigeno asociado con tumores
IL207012A0 (en) Diagnosis and therapy of cancer using sgp28-related molecules
CY1106200T1 (el) Αντισωματα εναντια σε κασπαση-8, παρασκευη και χρηση τους
UY26127A1 (es) Antígeno asociado con tumores
CY1111320T1 (el) Cripto ειδικα αντισωματα